AT357529B - METHOD FOR PRODUCING NEW 5- (SUBST. PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOGS - Google Patents
METHOD FOR PRODUCING NEW 5- (SUBST. PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOGSInfo
- Publication number
- AT357529B AT357529B AT868677A AT868677A AT357529B AT 357529 B AT357529 B AT 357529B AT 868677 A AT868677 A AT 868677A AT 868677 A AT868677 A AT 868677A AT 357529 B AT357529 B AT 357529B
- Authority
- AT
- Austria
- Prior art keywords
- oxazolidinones
- subst
- phenyl
- producing new
- sulfur analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/16—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762655369 DE2655369A1 (en) | 1976-12-03 | 1976-12-03 | 5- (SUBST. PHENYL) -OXAZOLIDINONE AND THEIR SULFUR ANALOGS AND PROCESS FOR THEIR PRODUCTION |
| DE19772745320 DE2745320A1 (en) | 1977-10-05 | 1977-10-05 | 5-Alkoxyphenyl-oxazolidine-2-one and sulphur analogues - useful as neuroleptics and phospho-di:esterase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA868677A ATA868677A (en) | 1979-12-15 |
| AT357529B true AT357529B (en) | 1980-07-10 |
Family
ID=25771221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT868677A AT357529B (en) | 1976-12-03 | 1977-12-05 | METHOD FOR PRODUCING NEW 5- (SUBST. PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOGS |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5382777A (en) |
| AT (1) | AT357529B (en) |
| AU (1) | AU519994B2 (en) |
| CA (1) | CA1097657A (en) |
| CH (1) | CH635578A5 (en) |
| CS (1) | CS199694B2 (en) |
| DD (1) | DD133667A5 (en) |
| DK (1) | DK149850C (en) |
| FR (1) | FR2372814A1 (en) |
| GB (1) | GB1588639A (en) |
| GR (1) | GR64964B (en) |
| HU (1) | HU175676B (en) |
| IE (1) | IE46435B1 (en) |
| IL (1) | IL53520A (en) |
| IT (1) | IT1089341B (en) |
| LU (1) | LU78616A1 (en) |
| NL (1) | NL7713153A (en) |
| SE (1) | SE441446B (en) |
| SU (1) | SU888821A3 (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2701215C2 (en) * | 1977-01-13 | 1982-10-14 | Bayer Ag, 5090 Leverkusen | Process for the preparation of thiazoline-2-thiones |
| US4348393A (en) * | 1978-06-09 | 1982-09-07 | Delalande S.A. | N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones |
| DE3438839A1 (en) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | PHARMACEUTICAL PREPARATIONS |
| US5459145A (en) * | 1988-01-19 | 1995-10-17 | Pfizer Inc. | Calcium independent camp phosphodiesterase inhibitor antidepressant |
| HU215433B (en) * | 1986-04-29 | 2000-05-28 | Pfizer Inc. | Process for producing new 2-oxo-5-phenyl-pyrimidin derivatives |
| JPH01135098U (en) * | 1988-03-11 | 1989-09-14 | ||
| WO1991007177A1 (en) * | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| US5461056A (en) * | 1992-05-08 | 1995-10-24 | Pfizer Inc. | Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders |
| GB9212673D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
| GB9222253D0 (en) * | 1992-10-23 | 1992-12-09 | Celltech Ltd | Chemical compounds |
| GB9226830D0 (en) * | 1992-12-23 | 1993-02-17 | Celltech Ltd | Chemical compounds |
| US5622977A (en) * | 1992-12-23 | 1997-04-22 | Celltech Therapeutics Limited | Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| GB9304919D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| DE69433594T2 (en) * | 1993-12-22 | 2004-08-05 | Celltech R&D Ltd., Slough | TRISUBSTITUTED PHENYL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF AS PHOSPHODIESTERASE (TYPE IV) INHIBITORS |
| GB9326173D0 (en) * | 1993-12-22 | 1994-02-23 | Celltech Ltd | Chemical compounds and process |
| US6245774B1 (en) | 1994-06-21 | 2001-06-12 | Celltech Therapeutics Limited | Tri-substituted phenyl or pyridine derivatives |
| US5786354A (en) * | 1994-06-21 | 1998-07-28 | Celltech Therapeutics, Limited | Tri-substituted phenyl derivatives and processes for their preparation |
| GB9412573D0 (en) | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412571D0 (en) * | 1994-06-22 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9412672D0 (en) * | 1994-06-23 | 1994-08-10 | Celltech Ltd | Chemical compounds |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526245D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9526246D0 (en) * | 1995-12-21 | 1996-02-21 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9608435D0 (en) * | 1996-04-24 | 1996-06-26 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9619284D0 (en) * | 1996-09-16 | 1996-10-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9622363D0 (en) | 1996-10-28 | 1997-01-08 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9625184D0 (en) * | 1996-12-04 | 1997-01-22 | Celltech Therapeutics Ltd | Chemical compounds |
| AU5330698A (en) | 1996-12-23 | 1998-07-17 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9705361D0 (en) * | 1997-03-14 | 1997-04-30 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9924862D0 (en) | 1999-10-20 | 1999-12-22 | Celltech Therapeutics Ltd | Chemical compounds |
-
1977
- 1977-11-28 SU SU772546252A patent/SU888821A3/en active
- 1977-11-29 NL NL7713153A patent/NL7713153A/en not_active Application Discontinuation
- 1977-12-01 LU LU78616A patent/LU78616A1/xx unknown
- 1977-12-01 SE SE7713635A patent/SE441446B/en not_active IP Right Cessation
- 1977-12-01 IT IT30254/77A patent/IT1089341B/en active
- 1977-12-01 DD DD7700202354A patent/DD133667A5/en unknown
- 1977-12-02 AU AU31175/77A patent/AU519994B2/en not_active Expired
- 1977-12-02 HU HU77SCHE632A patent/HU175676B/en not_active IP Right Cessation
- 1977-12-02 CH CH1477977A patent/CH635578A5/en not_active IP Right Cessation
- 1977-12-02 IL IL53520A patent/IL53520A/en unknown
- 1977-12-02 DK DK536677A patent/DK149850C/en not_active IP Right Cessation
- 1977-12-02 GB GB50350/77A patent/GB1588639A/en not_active Expired
- 1977-12-02 IE IE2446/77A patent/IE46435B1/en not_active IP Right Cessation
- 1977-12-02 JP JP14492277A patent/JPS5382777A/en active Granted
- 1977-12-02 CA CA292,273A patent/CA1097657A/en not_active Expired
- 1977-12-02 GR GR54913A patent/GR64964B/en unknown
- 1977-12-05 CS CS778086A patent/CS199694B2/en unknown
- 1977-12-05 AT AT868677A patent/AT357529B/en not_active IP Right Cessation
- 1977-12-05 FR FR7736525A patent/FR2372814A1/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| SU888821A3 (en) | 1981-12-07 |
| DD133667A5 (en) | 1979-01-17 |
| IL53520A (en) | 1981-07-31 |
| IL53520A0 (en) | 1978-03-10 |
| AU3117577A (en) | 1979-06-07 |
| JPS5382777A (en) | 1978-07-21 |
| DK149850B (en) | 1986-10-13 |
| NL7713153A (en) | 1978-06-06 |
| AU519994B2 (en) | 1982-01-07 |
| ATA868677A (en) | 1979-12-15 |
| HU175676B (en) | 1980-09-28 |
| GB1588639A (en) | 1981-04-29 |
| IE46435B1 (en) | 1983-06-15 |
| DK149850C (en) | 1987-04-27 |
| IE772446L (en) | 1978-06-03 |
| CA1097657A (en) | 1981-03-17 |
| SE7713635L (en) | 1978-06-04 |
| GR64964B (en) | 1980-06-10 |
| LU78616A1 (en) | 1978-04-20 |
| SE441446B (en) | 1985-10-07 |
| CS199694B2 (en) | 1980-07-31 |
| CH635578A5 (en) | 1983-04-15 |
| FR2372814A1 (en) | 1978-06-30 |
| IT1089341B (en) | 1985-06-18 |
| DK536677A (en) | 1978-06-04 |
| FR2372814B1 (en) | 1980-10-10 |
| JPS6154792B2 (en) | 1986-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT357529B (en) | METHOD FOR PRODUCING NEW 5- (SUBST. PHENYL) -OXAZOLIDINONES AND THEIR SULFUR ANALOGS | |
| ATA815577A (en) | METHOD FOR MANUFACTURING NEW SPIROL ACTONS | |
| AT358727B (en) | METHOD FOR PRODUCING NEW CEPHALOS PORINANTIBIOTICS | |
| AT356136B (en) | METHOD FOR PRODUCING NEW SPIRO-HYDANTOINES | |
| AT363478B (en) | METHOD FOR PRODUCING NEW OXEPANDERIVATIVES | |
| AT359187B (en) | METHOD FOR PRODUCING NEW 7-BETA- (2- -OXYIMINO-2-ARYLACETAMIDO) -CEPHALOSPORINES | |
| AT370110B (en) | METHOD FOR PRODUCING NEW 4-ANDROST-3-ONES | |
| AT360185B (en) | METHOD FOR PRODUCING NEW DEHYDRODIGOPEPTIDES | |
| AT353987B (en) | METHOD FOR PRODUCING NEW SPIROOXAZOLIDE INDIONS | |
| AT362786B (en) | METHOD FOR PRODUCING NEW 1-ACYL-2-IMIDAZOLINES | |
| AT358726B (en) | METHOD FOR PRODUCING NEW CEPHALOS PORINANTIBIOTICS | |
| AT351191B (en) | METHOD FOR PRODUCING NEW D-HOMOSTEROIDS | |
| AT375931B (en) | METHOD FOR PRODUCING NEW AMINOALKYLFURANDERIVATIVES | |
| AT364364B (en) | METHOD FOR PRODUCING NEW THIEPINES | |
| AT360646B (en) | METHOD FOR PRODUCING NEW CEPHALOS PORINES | |
| AT343623B (en) | METHOD FOR PRODUCING NEW N-ALKYL -4-NITRO-2-TRIFLUORMETHYLDIPHENYLAMINES | |
| AT356125B (en) | METHOD FOR PRODUCING NEW 1-ARYLOXY -2,3-EPOXYPROPANES | |
| ATA656076A (en) | METHOD FOR PRODUCING NEW D-HOMOSTEROIDS | |
| ATA175879A (en) | METHOD FOR PRODUCING NEW ANTITUM ORGLYCOSIDES | |
| AT361940B (en) | METHOD FOR PRODUCING NEW N, N'-THIO- BIS-OXIMCARBAMATES | |
| ATA272280A (en) | METHOD FOR PRODUCING NEW 1,4DIHYDROPYRIDINE COMPOUNDS | |
| AT355039B (en) | METHOD FOR PRODUCING NEW EATHED HYDROXY-BENZIMIDAZOLONES, - BENZOXAZOLONES, -BENZOXAZINONS, - CHINA-ZOLINONES AND -CHINOXAZOLINONES | |
| AT364367B (en) | METHOD FOR PRODUCING NEW OXEPINES | |
| AT355210B (en) | METHOD FOR PRODUCING NEW 1-OXA DETHIACEPHALOSPORINES | |
| ATA208580A (en) | METHOD FOR PRODUCING NEW D-HOMOSTEROIDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |